TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Volume of balloon required for 1st sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ischemia-driven revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mean difference in muscle symptom intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Half-life of ACT-1014-6470
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural errors during pretest for intrajugular CVC insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visible trembling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of SUVN-G3031
Endpoint domain: Adverse events/effects
Primary endpoint: Identification as at risk for suicide
Endpoint domain: Mortality/survival
Primary endpoint: Follow-up needs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Initiating mental health treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: youth-reported depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: dimensional changes after dry intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived lower retention after WOC following dry storage
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: more comfortable palate after WOC following wet intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvements in stool frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Communication improvement
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: decrease in IMT (∆IMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced levels of low-density lipoprotein cholesterol (LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of total adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Median anesthesia onset time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain scores on VAS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients successfully weaned from venovenous extracorporeal membrane oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Intra-examiner reliability for experienced assessors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-examiner reliability for novices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: respiratory severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: rescue surfactant use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Willingness to trade in-person visits for telehealth
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: motivation aspects of anhedonia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: percentage of non‐classical monocytes (CD14+CD16++) in blood circulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: percentage of blood CD3+CD4+ helper T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: percentage of blood CD4+CD25+ regulatory T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of neoplasms per colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Central alpha relative power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Risk of lymph node metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: relapse of fever
Endpoint domain: Adverse events/effects
Primary endpoint: 4 km cycling time trial performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of delayed cerebral ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: rescue fentanyl use
Endpoint domain: Adverse events/effects
Primary endpoint: PPPM scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications (vision loss)
Endpoint domain: Adverse events/effects
Primary endpoint: Impact of the intervention on depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Costs of the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Regression in the size of the lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the NPS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average gaze duration on facial features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall rates of complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: severity of complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Vascular access-site complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rates of pseudoaneurysms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Loss of insight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appetite changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychomotor retardation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of PAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of CAUTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Myeloproliferative Neoplasms Symptom Assessment Form total symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: grade 1 impaired hepatic function
Endpoint domain: Adverse events/effects
Primary endpoint: Static Physician's Global Assessment score of 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-emergent adverse events (Infections)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of women attempting intercourse
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Composite CRT response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete PK profiles obtained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-operative edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of nasal polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median percentage wound size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: harsh parenting
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bone healing after 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing time for the bony crypt surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Qualitative CBCT assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPM efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: freedom from late mortality and sudden cardiac death
Endpoint domain: Mortality/survival
Primary endpoint: postoperative LVOT gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain Catastrophizing Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EuroQol 5 Dimension‐3 levels questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 30‐second chair‐stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to deterioration of ECOG PS to ≥2
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Internal consistency reliability of MGDB scales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test-retest reliability over 2 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Convergent validity with TV parenting practices questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HADs anxiety scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: STAI-state anxiety scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: maximum dose delivered to the rectum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: D15cc to the bladder wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: necessity for adaptive planning
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Suicide discussion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 30-day or hospital mortality
Endpoint domain: Mortality/survival
Primary endpoint: self-reported physical disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: engagement in valued activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: chronic pain acceptance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: walking pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of EA at 15 min following extubation
Endpoint domain: Mortality/survival
Primary endpoint: Number of rescue fentanyl doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate to severe pain at 15 min following extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative HBeAg seroconversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: plasma levels of creatine kinase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: change in interleukin-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Viral Load (VL) >1000 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Viral Load (VL) >50 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Upper respiratory illness (URI) and/or fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum RSV-neutralizing titers increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved symptoms of posttraumatic stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved pediatric quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: greater reduction in problem behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: One month case fatality rate of SAH
Endpoint domain: Mortality/survival
Primary endpoint: One year case fatality rate of SAH
Endpoint domain: Mortality/survival
Primary endpoint: One month case fatality rate of ICH
Endpoint domain: Mortality/survival
Primary endpoint: One year case fatality rate of ICH
Endpoint domain: Mortality/survival
Primary endpoint: Post-delivery hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Drop in hemoglobin of 2 g/dL or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: surgical site infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Progression Rate (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: REU score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COMDQ score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average Cost-Effectiveness Ratio (ACER)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: MASI Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration–time curve (AUC0–tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate-to-vigorous PA/week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: phasic EMG events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cerebral oxygenation (crSO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cFTOE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laboratory-confirmed coronavirus infection
Endpoint domain: Adverse events/effects
Primary endpoint: Modified gingival index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crevicular interleukin (IL)-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Salivary matrix metalloproteinase (MMP)-9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in small LDL particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in large LDL particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FACT-Tax scores for hand numbness/tingling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: EORTC physical functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: FACT-TAX scores for discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rate
Endpoint domain: Adverse events/effects
Primary endpoint: MADRS scores change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differential diagnostic capability (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive impairment risk based on MMSE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: QALY difference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AUROC of STnLR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of progression measured in dB for 10-2 MD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of progression measured in dB for 24-2 MD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Loss of RNFL in μm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of head alignment on the odorant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total rTNSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PV score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood gas index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral blood flow (CBF) recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurologic score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vmax improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual field mean deviation improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of HbA1c < 7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Thigh CSA values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Knowledge regarding hepatitis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hygienic sanitary practices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hygienic practices related to drinking water
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LN response at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic Lupus Erythematosus Disease Activity Index score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trying to conceive in the past 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: stroke/systemic embolism (SEE)
Endpoint domain: Mortality/survival
Primary endpoint: full and partial remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate by 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative protein intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of double-organ bias
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Positioning accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average setup time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of acute treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Neonatal intensive care unit admission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: time to complete bowel care
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Open group climate scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient-reported benefit of mindfulness meditation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: composite of myocardial infarction or stent thrombosis
Endpoint domain: Mortality/survival
Primary endpoint: Bleeding Academic Research Consortium type 3 or 5 bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Participation rates of lower SES participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Macrolide resistance within BAPS17
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: restoration survival after 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Pulmonary embolism (PE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Kinematic benefit of femoral component positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal epithelial scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No cases of active TB
Endpoint domain: Mortality/survival
Primary endpoint: Proportions of patients experiencing AEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Progression to a superior ventilation modality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final External Rotation (ER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Range of Motion (TROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rates of MCT and LAT techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of injury-free trials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Physician procedure preference
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Poor outcome after acute stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: falls rate per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time spent completing paperwork
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Maximal change in blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decreasing mental health problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: increasing psychosocial resources
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in fasting blood markers for peptide tyrosine-tyrosine (PYY)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes